175-83.
164. Baumann F, Ruch M, Willenberg T, Dick F, Do DD, Keo HH, et al.
Endovascular treatment of common femoral artery obstructions.
J Vasc Surg 2011;53:1000-6.
165. Paris CL, White CJ, Collins TJ, Jenkins JS, Reilly JP, Grise MA, et al.
Catheter-based therapy of common femoral artery atherosclerotic
disease. Vasc Med 2011;16:109-12.
166. Chiu KW, Davies RS, Nightingale PG, Bradbury AW, Adam DJ.
Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg
2010;39:460-71.
167. Jaquinandi V, Picquet J, Saumet JL, Benharash P, Leftheriotis G,
Abraham P. Functional assessment at the buttock level of the effect of
aortobifemoral bypass surgery. Ann Surg 2008;247:869-76.
168. Juleff RS, Brown OW, McKain MM, Glover JL, Bendick PJ. The
inﬂuence of competitive ﬂow on graft patency. J Cardiovasc Surg
(Torino) 1992;33:415-9.
169. Pierce GE, Turrentine M, Stringﬁeld S, Iliopoulos J, Hardin CA,
Hermreck AS, et al. Evaluation of end-to-side v end-to-end proximal
anastomosis in aortobifemoral bypass. Arch Surg 1982;117:1580-8.
170. Brewster DC. Current controversies in the management of aortoiliac
occlusive disease. J Vasc Surg 1997;25:365-79.

38S Conte and Pomposelli et al

171. Malone JM, Moore WS, Goldstone J. Life expectancy following
aortofemoral